Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALLO - Allogene Therapeutics Inc. (ALLO) CEO David Chang on Q1 2022 Results - Earnings Call Transcript

ALLO - Allogene Therapeutics Inc. (ALLO) CEO David Chang on Q1 2022 Results - Earnings Call Transcript

Allogene Therapeutics Inc.
Allogene Therapeutics, Inc. (ALLO) Q1 2022 Earnings Conference Call May 04, 2022 05:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and Chief Executive Officer Rafael Amado - EVP of Research and Development and Chief Medical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Tyler Van Buren - Cowen Cory Kasimov - JP Morgan Salveen Richter - Goldman Sachs John Newman - Canaccord Luca Issi - RBC Capital Kalpit Patel - B. Riley Anand Sankar - Truist Raju Prasad - William Blair Dane Leone - Raymond James Presentation Operator Thank you for standing by, and Welcome to Allogene Therapeutics First Quarter 2022 Conference Call [Operator Instructions]. I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Please go ahead. Christine Cassiano Thank you, operator, and welcome to all who have joined this call. After the market closed

For further details see:

Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Allogene Therapeutics Inc.
Stock Symbol: ALLO
Market: NASDAQ
Website: allogene.com
Menu
ALLO ALLO Quote ALLO Short ALLO News ALLO Articles ALLO Message Board
Get ALLO Alerts

News, Short Squeeze, Breakout and More Instantly...